Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
Guardado en:
Autores principales: | James L Januzzi, Hanna K Gaggin, Megan Welch, Daniel A Zlotoff, Kevin Wei, Andrew Abboud, Austin Nguonly, Asher Bean, Kemar J Brown, Roy F Chen, David Dudzinski, Neyat Fiseha, Melvin Joice, Davis Kimaiyo, Mackenzie Martin, Christy Taylor |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0262efc8d2044357ae8907fe4b810b1d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
por: Mauro Gori, et al.
Publicado: (2021) -
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
por: Maria Vincenza Polito, et al.
Publicado: (2020) -
Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study
por: Michael C. Wang, et al.
Publicado: (2021) -
The Prognostic Value of Lung Ultrasound in Patients With Newly Diagnosed Heart Failure With Preserved Ejection Fraction in the Ambulatory Setting
por: Blanka Morvai-Illés, et al.
Publicado: (2021) -
New Adaptive Data Transmission Scheme Over HF Radio
por: Khalifa Abboud Salim, et al.
Publicado: (2008)